What are the opening hours?

Monday 09:00 - 18:00 Tuesday 09:00 - 18:00 Wednesday 09:00 - 18:00 Thursday 09:00 - 18:00 Friday 09:00 - 18:00

https://www.yingchitech.com/en/

YINGCHI, Block B, 2/F, Phoenix City Building, 15 Sci-tech North 1st Road, Xili, Shenzhen (2026)

17/08/2026

📢 𝗕𝗿𝗲𝗮𝗸𝗶𝗻𝗴 𝗡𝗲𝘄𝘀!

YINGCHI TMS system has now received both 𝗠𝗗𝗥 𝗮𝗻𝗱 𝗙𝗗𝗔 𝗰𝗹𝗲𝗮𝗿𝗮𝗻𝗰𝗲.

If you are considering adding navigation to your TMS workflow, or would like more information about the system, feel free to get in touch.

14/08/2026

𝗧𝗠𝗦 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁 𝗘𝘅𝗽𝗲𝗰𝘁𝗮𝘁𝗶𝗼𝗻𝘀: 𝗪𝗵𝗲𝗻 𝗗𝗼 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗕𝗲𝗴𝗶𝗻 𝘁𝗼 𝗦𝗲𝗲 𝗥𝗲𝘀𝘂𝗹𝘁𝘀 𝗳𝗿𝗼𝗺 𝗧𝗠𝗦?

🧠 A fundamental aspect of managing patient expectations during Transcranial Magnetic Stimulation ( ) therapy is establishing a realistic timeline for therapeutic outcomes. Clinical responses to neuromodulation accumulate over time rather than occurring instantaneously.

💡 In a standard clinical course for major depressive disorder ( ), many patients typically begin to notice a gradual improvement in depressive symptoms between the second and fourth weeks of consistent treatment. Because individual neuroplastic responses differ, the exact timeline for clinical improvement varies from person to person.

🚀 Discover how YINGCHI’s innovative can enhance your clinical operations. Visit our website to view our full medical device line, or contact us directly for details and inquiries.

🔗 https://en.yingchitech.com/

12/08/2026

𝗠𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝗶𝗻𝗴 𝗠𝗲𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝗶𝘁𝘆 𝗗𝘂𝗿𝗶𝗻𝗴 𝗧𝗠𝗦 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁

A common point of discussion during patient intake for Transcranial Magnetic Stimulation ( ) involves the management of existing psychiatric or neurological medications. It is not recommended to discontinue or adjust the dosage of prescribed medications without explicit direction from the treating physician.

In contemporary clinical practice, therapy is frequently co-administered alongside established medication regimens. The two treatment modalities generally operate safely in tandem without conflicting, allowing physicians to integrate neuromodulation into a patient's existing care plan without disrupting their current pharmacotherapy.

YINGCHI provides the solutions necessary to deliver precise, adaptable neuromodulation that aligns with modern clinical workflows. We invite you to visit our website to explore our full range of therapeutic technologies and contact our team to discuss how we can support your practice.

https://en.yingchitech.com/

04/08/2026

🧠 Transcranial Magnetic Stimulation ( ) provides an FDA-cleared, non-invasive therapeutic option for patients with Treatment-Resistant Depression and Obsessive-Compulsive Disorder ( ) who have not achieved adequate relief through traditional pharmacotherapy or psychotherapy.

💡 𝗠𝗮𝗷𝗼𝗿 𝗗𝗲𝗽𝗿𝗲𝘀𝘀𝗶𝘃𝗲 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿 𝗣𝗿𝗼𝘁𝗼𝗰𝗼𝗹𝘀
The treatment typically span 4 to 6 weeks, administered 5 days weekly. Depending on the clinical parameter selected, conventional daily sessions range from 19 to 37 minutes. Alternatively, Intermittent Theta Burst Stimulation ( ) protocols accelerate delivery, compressing active stimulation down to approximately 3 minutes and 18 seconds per session. Clinical data indicates that 50–60% of patients experience significant therapeutic relief without systemic side effects.

💡 𝗢𝗯𝘀𝗲𝘀𝘀𝗶𝘃𝗲-𝗖𝗼𝗺𝗽𝘂𝗹𝘀𝗶𝘃𝗲 𝗗𝗶𝘀𝗼𝗿𝗱𝗲𝗿 𝗣𝗿𝗼𝘁𝗼𝗰𝗼𝗹𝘀
For adult patients (ages 22 and older) experiencing refractory , targeted magnetic pulses modulate specific neural circuitry implicated in obsessive-compulsive behaviors. A standard course consists of approximately 30 to 36 non-sedative outpatient sessions delivered over 6 weeks.

YINGCHI provides the solutions necessary to deliver precise, adaptable neuromodulation that aligns with modern clinical workflows. Visit our website to explore our full range of therapeutic technologies and contact our team to discuss how we can support your practice.

https://en.yingchitech.com/

31/07/2026

⛩️ This week, YINGCHI is in Kobe, Japan, connecting with local neuroscientists, clinicians, and researchers.

🧠 We are excited to present our advanced systems directly to the local brain science community. Whether you are exploring functional brain mapping in motor function, cognitive tasks, or real-world behavioral studies, our team is on-site showing how can fit into your research workflows—from high-density signal acquisition to intuitive data analysis.

🔥 A huge thank you to everyone who took the time to visit our booth, exchange ideas with our team, and explore potential collaborations.

🚀 We are leaving Kobe thoroughly energized by the incredible work happening across Japan's research institutions. If we didn't get a chance to connect during the meeting, please feel free to reach out to us anytime!

👋 See you next time. またね

30/07/2026

𝗦𝗮𝗳𝗲𝘁𝘆 𝗣𝗿𝗼𝘁𝗼𝗰𝗼𝗹𝘀 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻: 𝗜𝗱𝗲𝗻𝘁𝗶𝗳𝘆𝗶𝗻𝗴 𝗔𝗯𝘀𝗼𝗹𝘂𝘁𝗲 𝗮𝗻𝗱 𝗥𝗲𝗹𝗮𝘁𝗶𝘃𝗲 𝗖𝗼𝗻𝘁𝗿𝗮𝗶𝗻𝗱𝗶𝗰𝗮𝘁𝗶𝗼𝗻𝘀 𝗳𝗼𝗿 𝗧𝗠𝗦 𝗧𝗵𝗲𝗿𝗮𝗽𝘆

💡 As Transcranial Magnetic Stimulation ( ) becomes an increasingly prominent modality in clinical care, establishing clear patient screening criteria is vital to maintaining the highest safety standards. Because operates through the application of pulsed magnetic fields, determining a patient's suitability requires a thorough evaluation for potential contraindications prior to initiating treatment.

🔎 Absolute contraindications apply primarily to individuals with non-removable electronic devices or ferromagnetic metal implants located within the head or face, such as cochlear implants and intracranial aneurysm clips or coils. Conversely, relative contraindications encompass patients with a history of seizures or those with implanted pulse generators, including cardiac pacemakers, defibrillators, vagus nerve stimulators, deep brain stimulators, cortical electrodes, and spinal cord stimulators. In these instances, treatment is not strictly precluded, but it demands a rigorous, individualized safety assessment conducted by the attending physician to carefully weigh clinical efficacy against potential operational risks.

💡 YINGCHI provides the solutions necessary to deliver precise, adaptable neuromodulation that aligns with modern clinical workflows. We invite you to visit our website to explore our full range of therapeutic technologies and contact our team to discuss how we can support your practice.

https://www.yingchi-tms.com/

28/07/2026

𝐍𝐞𝐰 𝐒𝐭𝐮𝐝𝐲 𝐢𝐧 𝐉𝐨𝐮𝐫𝐧𝐚𝐥 𝐨𝐟 𝐀𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 (𝐈𝐅 𝟓.𝟕) 𝐇𝐢𝐠𝐡𝐥𝐢𝐠𝐡𝐭𝐬 𝐍𝐞𝐮𝐫𝐚𝐥 𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧𝐬 𝐟𝐨𝐫 𝐒𝐨𝐜𝐢𝐚𝐥 𝐀𝐧𝐱𝐢𝐞𝐭𝐲

💡 Recently a research team from China published a landmark study investigating negative evaluation generalization—the core mechanism in Social Anxiety Disorder (SAD) where individuals improperly extend past negative feedback to safe social contexts.

🧠 Utilizing low-frequency (1Hz, 20 min) single-session targeted at the right dorsolateral prefrontal cortex (R-DLPFC), the study demonstrated that rTMS selectively attenuates overgeneralization toward highly ambiguous social cues (specifically moderate-similarity faces) during early generalization stages, without impairing foundational learning mechanisms.

𝐘𝐈𝐍𝐆𝐂𝐇𝐈 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐢𝐧 𝐀𝐜𝐭𝐢𝐨𝐧
🔥 We are proud to support this groundbreaking work. The research team utilized the YINGCHI M-100 Ultimate device paired with our MRI-guided TMS System, enabling individualized targeting to maximize spatial precision and research reliability.

🚀 YINGCHI remains committed to empowering global neuroscience with high-performance, turnkey solutions for precise psychiatric research and clinical applications.

🔗 Read the full study: https://doi.org/10.1016/j.jad.2026.121636

23/07/2026

𝗢𝘂𝘁𝗽𝗮𝘁𝗶𝗲𝗻𝘁 𝗖𝗮𝗿𝗲 𝗶𝗻 𝗡𝗲𝘂𝗿𝗼𝗺𝗼𝗱𝘂𝗹𝗮𝘁𝗶𝗼𝗻: 𝗠𝗮𝗶𝗻𝘁𝗮𝗶𝗻𝗶𝗻𝗴 𝗗𝗮𝗶𝗹𝘆 𝗥𝗼𝘂𝘁𝗶𝗻𝗲𝘀 𝗗𝘂𝗿𝗶𝗻𝗴 𝗧𝗠𝗦 𝗧𝗵𝗲𝗿𝗮𝗽𝘆

🧠 A primary logistical consideration for both clinicians and patients undergoing Transcranial Magnetic Stimulation ( ) is how treatment fits into day-to-day life. Because is a non-invasive physical procedure, it eliminates the need for general anesthesia, surgical intervention, or hospital admission.

💡 𝗡𝗲𝗴𝗹𝗶𝗴𝗶𝗯𝗹𝗲 𝗥𝗲𝗰𝗼𝘃𝗲𝗿𝘆 𝗥𝗲𝗾𝘂𝗶𝗿𝗲𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗗𝗮𝗶𝗹𝘆 𝗔𝗰𝘁𝗶𝘃𝗶𝘁𝗶𝗲𝘀
Unlike interventions requiring systemic medications, generally does not cause generalized side effects such as marked drowsiness, sedation, or cognitive impairment.

💡 𝗜𝗻𝘁𝗲𝗴𝗿𝗮𝘁𝗶𝗼𝗻 𝗶𝗻𝘁𝗼 𝗣𝗮𝘁𝗶𝗲𝗻𝘁 𝗦𝗰𝗵𝗲𝗱𝘂𝗹𝗲𝘀
Individuals can independently commute to and from their appointments and return to their professional, academic, or personal responsibilities directly following a session. This outpatient flexibility allows patients to maintain their standard daily routine while undergoing care.

YINGCHI provides the solutions necessary to deliver precise, adaptable neuromodulation that aligns with modern clinical workflows. We invite you to visit our website to explore our full range of therapeutic technologies and contact our team to discuss how we can support your practice.

21/07/2026

𝗖𝗹𝗼𝘀𝗲𝗱-𝗟𝗼𝗼𝗽 𝗧𝗠𝗦–𝗘𝗘𝗚 & 𝗕𝗿𝗮𝗶𝗻–𝗖𝗼𝗺𝗽𝘂𝘁𝗲𝗿 𝗜𝗻𝘁𝗲𝗿𝗳𝗮𝗰𝗲 (𝗕𝗖𝗜) 𝗪𝗼𝗿𝗸𝘀𝗵𝗼𝗽

📢 Last week, YINGCHI successfully hosted an intensive workshop at the vibrate city of Guangzhou, focused on closed-loop TMS–EEG and its growing clinical applications.

♻️ As one of the most promising frontiers in Brain–Computer Interface ( ) technology and precision neuromodulation, 𝗰𝗹𝗼𝘀𝗲𝗱-𝗹𝗼𝗼𝗽 𝗧𝗠𝗦-𝗘𝗘𝗚 (𝗕𝗿𝗮𝗶𝗻-𝗦𝘁𝗮𝘁𝗲 𝗗𝗲𝗽𝗲𝗻𝗱𝗲𝗻𝘁 𝗦𝘁𝗶𝗺𝘂𝗹𝗮𝘁𝗶𝗼𝗻) is reshaping and brain disorder diagnostics. By combining the high spatial precision of with the temporal accuracy of , this workshop delivered a complete end-to-end framework—bridging clinical perspectives, theoretical foundations, system design, and hands-on operational training.

🚀 During the event, YINGCHI highlighted our advanced TMS–EEG closed-loop solution. The system enables real-time signal analysis to trigger pulses the exact moment specific brain states are detected, ensuring seamless synchronization with individual neural activity. Built to address real-world laboratory and clinical challenges, our solution delivers robust artifact suppression and millisecond-level precision, capturing clean, reliable signals during active stimulation.

🧠 The event marked a major step forward in moving researchers and clinicians away from traditional open-loop paradigms toward intelligent, personalized neuromodulation.

🫶 A sincere thank you to all the speakers and participants who joined us. YINGCHI remains dedicated to empowering the global neuroscience community with cutting-edge tools and integrated solutions.

16/07/2026

𝐔𝐧𝐝𝐞𝐫𝐬𝐭𝐚𝐧𝐝𝐢𝐧𝐠 𝐒𝐞𝐬𝐬𝐢𝐨𝐧 𝐒𝐞𝐭𝐭𝐢𝐧𝐠 𝐚𝐧𝐝 𝐃𝐮𝐫𝐚𝐭𝐢𝐨𝐧 𝐢𝐧 𝐓𝐌𝐒 𝐓𝐡𝐞𝐫𝐚𝐩𝐲

⚡ When integrating into a clinical practice or managing patient expectations, the temporal commitment required for the therapeutic course is also a primary logistical consideration. TMS session number setting can vary based on the specific protocol prescribed by the attending physician.

💡 𝐂𝐨𝐧𝐯𝐞𝐧𝐭𝐢𝐨𝐧𝐚𝐥 𝐏𝐫𝐨𝐭𝐨𝐜𝐨𝐥𝐬 𝐯𝐬. 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐞𝐝 𝐏𝐚𝐫𝐚𝐝𝐢𝐠𝐦𝐬
The duration of individual treatment sessions depend on the specific neurostimulatory methodology deployed:
Standard Conventional Protocols: These traditional paradigms typically require a duration of 20 to 40 minutes per session to deliver the prescribed therapeutic dose.
Theta Burst Stimulation ( ): Utilizing advanced, accelerated neuroplastic paradigms, compresses individual treatment times down to approximately 3 minutes per session, increasing patient throughput without compromising clinical efficacy.

💡 𝐓𝐡𝐞 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜 𝐂𝐨𝐮𝐫𝐬𝐞
Beyond the daily session setting, the overall timeline is structured to achieve cumulative neuromodulatory effects. A standard acute treatment regimen generally extends across a 4-to-6-week window. During this course, treatments are administered consecutively 5 days per week, typically scheduled Monday through Friday.

🚀 YINGCHI provides the solutions necessary to deliver adaptable neuromodulation that aligns with modern clinical workflows. We invite you to visit our website to explore our full range of therapeutic technologies and contact our team to discuss how we can support your practice.

https://en.yingchitech.com/

YINGCHI

17/08/2026

14/08/2026

12/08/2026

04/08/2026

31/07/2026

30/07/2026

28/07/2026

23/07/2026

21/07/2026

16/07/2026

Address

Opening Hours

Website

Alerts

Contact The Business

Shortcuts

Share

Category

Listing takedown request

Monday	09:00 - 18:00
Tuesday	09:00 - 18:00
Wednesday	09:00 - 18:00
Thursday	09:00 - 18:00
Friday	09:00 - 18:00